Generation of a Novel Rat Model of Angelman Syndrome with a Complete Ube3a Gene Deletion.
Andie Dodge, Melinda M Peters, Hayden E Greene and 17 others
PMID 31961493WHAT IT FOUND
A new rat model of Angelman syndrome shows motor and memory deficits similar to humans, including hind-limb clasping, poor coordination, and social interaction issues.
It lacks the weight gain seen in mouse models, making it a potentially more accurate tool for testing future therapies.
Key findings
01The maternal Ube3a deletion rats displayed significant motor deficits, including hind-limb clasping, poor performance on the rotarod, and altered gait symmetry compared to wild-type littermates.
02The rats showed deficits in both contextual and cued fear conditioning and reduced social interaction, particularly in males, but no significant difference in novel object recognition.
03Unlike the Angelman syndrome mouse model, these rats did not exhibit excess weight gain, which removes a potential confound in motor testing.
STILL TO COME
How it was doneWhat they found
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
This is an animal model study; findings have not been replicated in humans. Social interaction deficits were predominantly seen in male rats, with no significant difference in females. The study did not assess speech or language outcomes, which are key features of Angelman syndrome. Some behavioral deficits, such as fear conditioning, were not observed in all previous mouse models, suggesting potential species or strain differences.
Declared interests
The authors declared no competing interests. The work was supported by non-U.S. government funding.
The easy way to misread this
Do not interpret the motor and memory deficits in these rats as direct evidence of what will happen in human patients or as proof that a therapy will work. This paper describes the creation and characterization of an animal model for future research, not a clinical trial in humans.